Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT07439757

AI-Powered Precision Decision-Making for Pancreatic Diseases

Led by Changhai Hospital · Updated on 2026-02-27

2000

Participants Needed

1

Research Sites

191 weeks

Total Duration

On this page

Sponsors

C

Changhai Hospital

Lead Sponsor

T

The First Affiliated Hospital with Nanjing Medical University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This multicenter clinical trial evaluates an artificial intelligence (AI) system designed to assist in the diagnosis and management of pancreatic diseases. Using contrast-enhanced CT scans, the study compares the AI's recommendations against the decisions of experienced clinicians to verify the system's accuracy and safety in a real-world setting. Patients are categorized into three management groups: Intervention (surgery/treatment), Intensive Surveillance (close monitoring), or Routine Surveillance (standard follow-up). The primary goal is to determine if the AI system can reliably classify patients, reduce the risk of missing malignant lesions, and prevent unnecessary surgeries, thereby improving clinical decision-making for pancreatic conditions.

CONDITIONS

Official Title

AI-Powered Precision Decision-Making for Pancreatic Diseases

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinically suspected pancreatic disease
  • Scheduled to undergo contrast-enhanced CT
  • Signed informed consent form indicating agreement to participate
Not Eligible

You will not qualify if you...

  • History of pancreatic surgery
  • Contraindications to contrast-enhanced CT, including known hypersensitivity to iodinated contrast media or severe renal/hepatic dysfunction
  • Suboptimal image quality affecting diagnosis
  • Concurrent participation in another interventional clinical trial
  • Unsuitability for participation as determined by the investigator, including pregnancy or lactation, severe psychiatric disorders or cognitive impairment, or significant comorbidities that may interfere with study results or patient safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Changhai Hospital

Shanghai, China, 200433

Actively Recruiting

Loading map...

Research Team

B

Beilei Wang, Doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here